Real‐time quantitative RT‐PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro
Top Cited Papers
- 1 January 2002
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 85 (4), 737-746
- https://doi.org/10.1002/jcb.10174
Abstract
We developed and used real‐time RT‐PCR assays to investigate how the expression of typical osteoblast‐related genes by human bone marrow stromal cells (BMSC) is regulated by (i) the culture time in medium inducing osteogenic differentiation and (ii) the previous expansion in medium enhancing cell osteogenic commitment. BMSC from six healthy donors were expanded in medium without (CTR) or with fibroblast growth factor‐2 and dexamethasone (FGF/Dex; these factors are known to increase BMSC osteogenic commitment) and further cultivated for up to 20 days with ascorbic acid, β‐glycerophosphate and dexamethasone (these factors are typically used to induce BMSC osteogenic differentiation). Despite a high variability in the gene expression levels among different individuals, we identified the following statistically significant patterns. The mRNA levels of bone morphogenetic protein‐2 (BMP‐2), bone sialo protein‐II (BSP), osteopontin (OP) and to a lower extent cbfa‐1 increased with culture time in osteogenic medium (OM), both in CTR‐ and FGF/Dex‐expanded BMSC, unlike levels of alkaline phosphatase, collagen type I, osteocalcin, and osteonectin. After 20 days culture in OM, BMP‐2, BSP, and OP were more expressed in FGF/Dex than in CTR‐expanded BMSC (mRNA levels were, respectively, 9.5‐, 14.9‐, and 5.8‐fold higher), unlike all the other investigated genes. Analysis of single‐colony‐derived strains of BMSC further revealed that after 20 days culture in OM, only a subset of FGF/Dex‐expanded clones expressed higher mRNA levels of BMP‐2, BSP, and OP than CTR‐expanded clones. In conclusion, we provide evidence that mRNA levels of BMP‐2, BSP, and OP, quantified using real‐time RT‐PCR, can be used as markers to monitor the extent of BMSC osteogenic differentiation in vitro; using those markers, we further demonstrated that only a few subpopulations of BMSC display enhanced osteogenic differentiation following FGF/Dex expansion. J. Cell. Biochem. 85: 737–746, 2002.Keywords
Funding Information
- Swiss Federal Office for Education and Science (Bundesamtfuer Bildung und Wissenschaft, BBW) under the Fifth European Framework Growth Program (SCAFCART) (99.0291)
This publication has 32 references indexed in Scilit:
- Bone SialoproteinCritical Reviews in Oral Biology & Medicine, 1999
- Single-Colony Derived Strains of Human Marrow Stromal Fibroblasts Form Bone After Transplantation In VivoJournal of Bone and Mineral Research, 1997
- A novel method for real time quantitative RT-PCR.Genome Research, 1996
- Expression of bone matrix proteins during dexamethasone-induced mineralization of human bone marrow stromal cellsJournal of Cellular Biochemistry, 1996
- Isolation and characterization of osteoblast precursor cells from human bone marrowJournal of Bone and Mineral Research, 1996
- Rat tail suspension reduces messenger RNA level for growth factors and osteopontin and decreases the osteoblastic differentiation of bone marrow stromal cellsJournal of Bone and Mineral Research, 1995
- Localization of bone sialoprotein (BSP) to Golgi and post-Golgi secretory structures in osteoblasts and to discrete sites in early bone matrix.Journal of Histochemistry & Cytochemistry, 1993
- Osteogenic Stem Cells and the Stromal System of Bone and MarrowClinical Orthopaedics and Related Research, 1989
- Bone Morphogenetic ProteinsProgress in Growth Factor Research, 1989
- Conditions controlling the proliferation of haemopoietic stem cells in vitroJournal of Cellular Physiology, 1977